CD4 and endometrium adenocarcinoma: Critical immune cells, including M1 macrophages, memory-activated CD4+ T cells, CD8+ T cells, and follicular helper T cells, have been proven beneficial to the survival of endometrial adenocarcinoma patients, and the exact underlying mechanism needs to be further studied.